Amyloid-β Peptide-specific DARPins as a Novel Class of Potential Therapeutics for Alzheimer Disease
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Amyloid-β Peptide-specific DARPins as a Novel Class of Potential Therapeutics for Alzheimer Disease
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 289, Issue 39, Pages 27080-27089
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2014-08-13
DOI
10.1074/jbc.m114.564013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DARPins and other repeat protein scaffolds: advances in engineering and applications
- (2011) Ykelien L Boersma et al. CURRENT OPINION IN BIOTECHNOLOGY
- ‘Clinical trials in Alzheimer’s disease’: immunotherapy approaches
- (2011) Julien Delrieu et al. JOURNAL OF NEUROCHEMISTRY
- Robust Amyloid Clearance in a Mouse Model of Alzheimer's Disease Provides Novel Insights into the Mechanism of Amyloid- Immunotherapy
- (2011) A. Wang et al. JOURNAL OF NEUROSCIENCE
- Resolving controversies on the path to Alzheimer's therapeutics
- (2011) Dennis J Selkoe NATURE MEDICINE
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
- (2011) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- Chronic Intranasal Treatment with an Anti-Aβ30-42 scFv Antibody Ameliorates Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease
- (2011) Susann Cattepoel et al. PLoS One
- Efficient Tumor Targeting with High-Affinity Designed Ankyrin Repeat Proteins: Effects of Affinity and Molecular Size
- (2010) C. Zahnd et al. CANCER RESEARCH
- Safety and Changes in Plasma and Cerebrospinal Fluid Amyloid β After a Single Administration of an Amyloid β Monoclonal Antibody in Subjects With Alzheimer Disease
- (2010) Eric R. Siemers et al. CLINICAL NEUROPHARMACOLOGY
- Micelle-Like Architecture of the Monomer Ensemble of Alzheimer’s Amyloid-β Peptide in Aqueous Solution and Its Implications for Aβ Aggregation
- (2010) Andreas Vitalis et al. JOURNAL OF MOLECULAR BIOLOGY
- 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
- (2010) Juha O Rinne et al. LANCET NEUROLOGY
- Alzheimer's disease: strategies for disease modification
- (2010) Martin Citron NATURE REVIEWS DRUG DISCOVERY
- Surface Plasmon Resonance Binding Kinetics of Alzheimer’s Disease Amyloid β Peptide-Capturing and Plaque-Binding Monoclonal Antibodies
- (2009) Muthu Ramakrishnan et al. BIOCHEMISTRY
- The Recombinant Amyloid-β Peptide Aβ1–42 Aggregates Faster and Is More Neurotoxic than Synthetic Aβ1–42
- (2009) Verena H. Finder et al. JOURNAL OF MOLECULAR BIOLOGY
- A Immunotherapy Protects Morphology and Survival of Adult-Born Neurons in Doubly Transgenic APP/PS1 Mice
- (2009) B. Biscaro et al. JOURNAL OF NEUROSCIENCE
- DARPins: A new generation of protein therapeutics
- (2008) Michael T. Stumpp et al. DRUG DISCOVERY TODAY
- Rapid Microglial Response Around Amyloid Pathology after Systemic Anti-A Antibody Administration in PDAPP Mice
- (2008) J. Koenigsknecht-Talboo et al. JOURNAL OF NEUROSCIENCE
- 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease
- (2008) Norman R. Relkin et al. NEUROBIOLOGY OF AGING
- Folding and Unfolding Mechanism of Highly Stable Full-Consensus Ankyrin Repeat Proteins
- (2007) Svava K. Wetzel et al. JOURNAL OF MOLECULAR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search